Table 3 Bivariate analysis for socio-demographic and viral suppression after IAC
Variable | Category | TOTAL = 283 | Suppressed after IAC | P-Value | |
|---|---|---|---|---|---|
Frequency (Percentage) | No [Frequency (Percentage)] TOTAL = 73 | Yes [Frequency (Percentage)] TOTAL = 210 | |||
Socio-demographic characteristics | |||||
Age in completed years | < 15 | 58 (20.49) | 18 (24.66) | 40 (19.05) | 0.53 |
15 - 24 | 28 (9.89) | 9 (12.33) | 19 (9.05) | Â | |
25 - 34 | 37 (13.07) | 6 (8.22) | 31 (14.76) | Â | |
35 - 44 | 65 (22.97) | 18 (24.66) | 47 (22.38) | Â | |
45 - 54 | 58 (20.49) | 12 (16.44) | 46 (21.9) | Â | |
55+ Years | 37 (13.07) | 10 (13.7) | 27 (12.86) | Â | |
Sex | Female | 161 (56.89) | 47 (64.38) | 114 (54.29) | 0.133 |
Male | 122 (43.11) | 26 (35.62) | 96 (45.71) | Â | |
Marital Status | Married | 144 \(50.88) | 34 (46.58) | 110 (52.38) | 0.393 |
Not Married | 139 (49.12) | 39 (53.42) | 100 (47.62) | Â | |
Has children | Yes | 201 (71.02) | 45 (61.64) | 156 (74.29) | 0.040* |
No | 82 (29.98) | 28 (38.36) | 54 (25.71) | Â | |
Living Area | Rural | 177 (62.54) | 43 (58.90) | 134 (63.81) | 0.456 |
Town | 106 (37.46) | 30 (41.10) | 76 (36.19) | Â | |
Education | None | 60 (21.2) | 15 (20.55) | 45 (21.43) | 0.742 |
Primary | 158 (55.83) | 43 (58.90) | 115 (54.76) | Â | |
Secondary | 60 (21.2) | 13 (17.81) | 47 (22.38) | Â | |
University | 5 (1.77) | 2 (2.74) | 3 (1.43) | Â | |
Personal characteristics | |||||
Substance user± | No | 159 (74.65) | 36 (75.00) | 123 (74.55) | 0.949 |
Yes | 54 (25.35) | 12 (25.00) | 42 (25.45) | Â | |
Ever missed an ART appointment | No | 158 (55.83) | 37 (50.68) | 121 (57.62) | 0.304 |
Yes | 125 (44.17) | 36 (49.32) | 89 (42.38) | Â | |
Ever been represented on ART | No | 198 (69.96) | 42 (57.53) | 156 (74.29) | 0.007** |
Yes | 85 (30.04) | 31 (42.47) | 54 (25.71) | Â | |
Represented while on IAC | No | 234 (82.69) | 51 (69.86) | 183 (87.14) | 0.001** |
Yes | 49 (17.31) | 22 (30.14) | 27 (12.86) | Â | |
Duration on ART | <5 years | 237 (83.75) | 22 (30.14) | 55 (26.19) | 0.514 |
>5 years | 46 (16.25) | 51 (69.86) | 155 (73.81) | Â | |
Caregiver support | No | 11 (3.89) | 5 (6.85) | 6 (2.86) | 0.128 |
Yes | 272 (96.11) | 68 (93.15) | 204 (97.14) | Â | |
Clinical characteristics | |||||
Viral load at baseline (ART start) in c/m | >1000 | 69 (25.56) | 28 (41.79) | 41 (20.20) | <0.001*** |
≤1000 | 201 (74.44) | 39 (58.21) | 162 (79.80) |  | |
Viral load before IAC in c/m | 1000-2000 | 130 (45.94) | 18 (24.66) | 112 (53.33) | <0.001*** |
>2000 | 153 (54.06) | 55 (75.34) | 98 (46.67) | Â | |
Previous history of a high viral load | No | 153 (54.06) | 22 (30.14) | 131 (62.38) | <0.001*** |
Yes | 130 (45.94) | 51 (69.86) | 79 (37.62) | Â | |
Normal body mass index | No | 239 (84.45) | 56 (76.71) | 27 (12.86) | 0.034* |
Yes | 44 (15.55) | 17 (23.29) | 183 (87.14) | Â | |
Disease stage at ART initiation | Stage 2 or Later | 63 (22.26) | 21 (28.77) | 42 (20.00) | 0.121 |
Stage 1 | 220 (77.74) | 52 (71.23) | 168 (80.00) | Â | |
Ever bedridden during ART | No | 228 (80.57) | 56 (76.71) | 172 (81.90) | 0.334 |
Yes | 55 (19.43) | 17 (23.29) | 38 (18.10) | Â | |
Disease stage at IAC | Stage 2 or Later | 59 (20.85) | 18 (24.66) | 41 (19.52) | 0.352 |
Stage 1 | 224 (79.15) | 55 (75.34) | 169 (80.48) | Â | |
ART Side effects | No | 206 (72.79) | 50 (68.49) | 156 (74.29) | 0.338 |
Yes | 77 (27.21) | 23 (31.51) | 54 (25.71) | Â | |
Adverse events | No | 279 (98.59) | 69 (94.52) | 210 (100.00) | 0.004** |
Yes | 4 (1.41) | 4 (5.48) | 0 (0.00) | Â | |
Had an infection while on IAC | No | 256 (94.12) | 59 (86.76) | 197 (96.57) | 0.003** |
Yes | 16 (5.88) | 9 (13.24) | 7 (3.43) | Â | |
Regimen | Second or higher | 105 (37.1) | 36 (49.32) | 69 (32.86) | 0.012* |
First regiment | 178 (62.9) | 37 (50.68) | 141 (67.14) | Â | |